Windy City Media Group Frontpage News

THE VOICE OF CHICAGO'S GAY, LESBIAN, BI, TRANS AND QUEER COMMUNITY SINCE 1985

home search facebook twitter join
Gay News Sponsor Windy City Times 2023-12-13
DOWNLOAD ISSUE
Donate

Sponsor
Sponsor
Sponsor

  WINDY CITY TIMES

HIV Vaccines: Optimism and Frustration
by Bob Roehr
2001-05-23

This article shared 1130 times since Wed May 23, 2001
facebook twitter google +1 reddit email


The search for a vaccine against HIV got a huge boost when President Bill Clinton committed to developing one by 2007 in a speech at Morgan State University in 1997. Few doubt the need. An estimated 15,000 new infections a day occur throughout the world, most in nations too poor to afford therapy. Prevention is key, and a vaccine is the ideal capstone to prevention activities.

The AIDS Vaccine Advocacy Coalition ( AVAC ) has used the May 18 anniversary of Clinton's speech to issue an annual report on progress made toward the goal of an AIDS vaccine. This year's edition, "6 Years and Counting" [ down ] , offers an upbeat assessment of momentum gained over the last year.

But huge problems remain and major questions seem no closer to being answered than they were at the start of the epidemic. That became apparent in a May 16 phone news conference that AVAC had with reporters.

On the plus side, AVAC executive director Rose McCullough counted "several new and interesting studies in monkeys of vaccine that have demonstrated good levels of protection;" increased participation by industry in HIV vaccine research by many whom had earlier shunned such activity; continued and increased research funded by the National Institutes of Health ( NIH ) ; and many more candidate vaccines that are about ready to enter human trials.

She said, "The promise of that progress requires a new level of political and scientific leadership." That includes continued increased funding of research; passage of tax credits to draw industry's commitment; and expansion of global capacity to test vaccines in the populations most affected. It will require leadership from the United States.

BASIC SCIENCE

But as everybody readily admits, vaccine trials in monkeys are not the same as trials in humans. At the level of basic science, monkeys do not become infected with HIV so researchers use a simian virus ( SIV ) , somewhat akin to HIV. Most monkey trials vaccinate the animal, wait long enough for protection to develop, then expose it to a single dose of SIV high enough to infect 100 percent of unprotected animals. Six months later, if the animal does not develop infection, the vaccine is considered a success.

This may be good science, but it does not reflect the way humans are likely to be exposed to HIV though continuous sexual activity. Nor does it reflect the fact that levels of protection with many vaccines decline over time. There is some evidence to suggest that the protection from HIV may fall especially quickly, perhaps in just a few months.

Researchers followed a small group of prostitutes in Kenya who were continuously exposed to HIV yet did not become infected with the virus. These few examples offered hope that it was possible to develop a natural immune protection from infection, and hence a vaccine. But many of these women developed HIV when they took a break from the trade and then went back to it after a few months. This suggests that they needed constant exposure to HIV to maintain their natural defenses and that those defenses fall rather quickly once exposure is reduced.

Many people see as a hopeful sign the fact that about a dozen candidate vaccines are nearly ready for human trials. The vaccines cover a huge range of approaches, use various different parts of the HIV genome, boosting agents, and inoculation strategies to try to elicit immune protection.

But the very diversity of approaches is an indication of how little we know about "the correlates of protection," of what is the critical immune response that people need in order to fight off HIV infection. "We don't have that information yet," said Susan Buchbinder during the conference call. She is a vaccine researcher at the University of California San Francisco. She hopes that some of that information will come from initial large-scale trials "to help guide future efforts."

Another open question is whether a single vaccine can be developed that is effective against all of the strains of HIV. Researchers have identified a handful of major strains of the virus, each with multiple variations.

Influenza ( the common flu ) , like HIV, is another highly divergent and rapidly mutating virus. New variations of the flu vaccine have to be prepared and populations inoculated on an annual basis to afford some protection.

PROTECTING PEOPLE

"Sterilizing immunity" represents the optimum goal of a vaccine. It means that a person will completely resist exposure to a virus and no trace of it will be left in their body. Most researchers believe that an HIV vaccine will not protect 100 percent of those who receive it, at least not initially and perhaps ever.

While some people may be protected, the initial vaccines likely will prime the immune system so that any infection is a kinder, gentler version of HIV disease that develops more slowly and can be better controlled.

"You could argue that in some parts of the world it would be better to slow disease progression than not to do anything at all," said Buchbinder. It may be that countries and risk groups make different decisions on about when it makes sense to use a vaccine with limited effectiveness.

Complicating the matter further is the issue of "therapeutic vaccines." Can a vaccine or another agent that is given after a person becomes infected, help boost the immune response to better control HIV infection? The answer seems to be yes. And that makes the risk/benefit of a vaccine that offers only limited protection even more difficult to evaluate.

The practical matter is that it takes a minimum of four years to complete early phase I and II trials that test for safety and immune response in small groups of people. Phase III trials, the larger population studies that test vaccines under real world conditions to evaluate their protective power, take even longer.

Only three products have even entered human trials, and expectations for them are muted. As David Gilden, with the American Foundation for AIDS Research ( amfAR ) , concluded, "It is going to take at least a decade to begin to see if a vaccine is partially effective, at best."


This article shared 1130 times since Wed May 23, 2001
facebook twitter google +1 reddit email

Out and Aging
Presented By

  ARTICLES YOU MIGHT LIKE

Gay News

WORLD Uganda items, HIV report, Mandela, Liechtenstein, foreign minister weds
2024-03-21
It turned out that U.S. Agency for International Development (USAID) Senior LGBTQI+ Coordinator Jay Gilliam traveled to Uganda on Feb. 19-27, per The Washington Blade. He visited the capital of Kampala and the nearby city of ...


Gay News

NATIONAL Missouri measure, HIV/AIDS Awareness Day, judge, Texas schools
2024-03-15
In Missouri, a newly proposed law could charge teachers and counselors with a felony and require them to register as sex offenders if they're found guilty of supporting transgender students who are socially transitioning, CNN noted. ...


Gay News

Longtime LGBTQ+-rights activist David Mixner dies at 77
2024-03-12
On March 11, longtime LGBTQ+ and HIV/AIDS activist David Mixner—known for working on Bill Clinton's presidential campaign but then splitting from him over "Don't Ask, Don't Tell" (DADT)—died at age 77, The Advocate reported. ...


Gay News

AMA launches toolkit to increase screenings for HIV, STIs, hepatitis, tuberculosis
2024-03-06
Press release - CHICAGO — With disruptions in clinical care caused by the COVID-19 pandemic and increasing rates of sexually transmitted infections (STIs) and viral hepatitis across the U.S., the American Medical Association ...


Gay News

NATIONAL School items, HIV/AIDS activist dies, Nex Benedict, inclusive parade
2024-03-01
In a new survey, the Pew Research Center asked public K-12 teachers, teens and the U.S. public about the ongoing scrutiny placed on classroom curricula, mainly regarding race and LGBTQ+ identities, ABC News noted. Among other ...


Gay News

Advocates call for increased HIV funding amid state's 'disappointing' pattern of flat funding
2024-02-27
Governor JB Pritzker's proposed 2025 budget has no increase in HIV funding, continuing a years-long pattern of flat spending toward tackling the epidemic in Illinois. Pritzker outlined his $52.7 billion budget for the 2025 fiscal year ...


Gay News

HIV criminal laws disproportionately impact Black men in Mississippi
2024-02-21
--From a press release - A new report by the Williams Institute at UCLA School of Law finds that at least 43 people in Mississippi were arrested for HIV-related crimes between 2004 and 2021. Half of all arrests in the state ...


Gay News

'West Side Story' gets a sex-positive spin with new burlesque show
2024-02-19
In partial observance of National Condom Day, which was Feb. 14, Los Angeles-based AIDS Healthcare Foundation (AHF) presented A West Side Story Burlesque at the Harris Theater for two hour-long performances on Feb. 17. The show, ...


Gay News

$200,000+ raised at AIDS Foundation Chicago's World of Chocolate Fundraiser to fight HIV/AIDS
2024-02-13
--From a press release - (Chicago, IL) More than 950 guests gathered at Chicago's famed Union Station (500 W. Jackson) for Chicago's Sweetest Fundraiser, AIDS Foundation Chicago's (AFC), World of Chocolate on Friday, February 9. ...


Gay News

THEATER Dot-Marie Jones talks Goodman production, 'Glee,' 'Bros'
2024-02-12
Running through Feb. 18 at the the Goodman Theatre, the production Highway Patrol works with a script conceived entirely from Emmy-winning actor Dana Delany's (TV's China Beach) digital archive of hundreds of tweets and direct messages ...


Gay News

Munar prepares to step away from Howard Brown leadership
2024-02-11
After 10 years of leadership at Howard Brown Health, President and CEO David Ernesto Munar has decided to step down from his post on Feb. 29. Munar, who'd previously been president and CEO of AIDS Foundation ...


Gay News

Chicagoans indulge in a World of Chocolate
2024-02-11
AIDS Foundation of Chicago hosted its 2024 World of Chocolate celebration the evening of Feb. 9 at Union Station. Top chocolatiers from across the city allowed guests to sample numerous confections, hors d'oevres and libations for ...


Gay News

Pritzker Military Library to close in July, move to Wisconsin
2024-02-08
On Feb. 7, the Pritzker Military Museum & Library announced that it is closing its downtown Chicago location on July 27 and moving to an archives center in Wisconsin later this year, according to The Chicago ...


Gay News

National Black Justice Coalition commemorates National Black HIV/AIDS Awareness Day
2024-02-07
--From a press release - WASHINGTON — Today, Feb. 7, marks National Black HIV/AIDS Awareness Day (NBHAAD). In commemoration, Dr. David J. Johns, CEO of the National Black Justice Coalition (NBJC), a leading Black LGBTQ+/same-gender ...


Gay News

SAVOR Chocolatier Uzma Sharif on being part of World of Chocolate
2024-02-03
AIDS Foundation Chicago will hold its annual World of Chocolate event on Friday, Feb. 9, at 6 p.m. at Union Station, 500 W. Jackson Blvd. Attendees will embark on a global tour of chocolate—but there will ...


 


Copyright © 2024 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.

All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transgender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 
 

TRENDINGBREAKINGPHOTOS







Sponsor


 



Donate


About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots
Identity      BLACKlines      En La Vida      Archives      Advanced Search     
Windy City Queercast      Queercast Archives     
Press  Releases      Join WCMG  Email List      Email Blast      Blogs     
Upcoming Events      Todays Events      Ongoing Events      Bar Guide      Community Groups      In Memoriam     
Privacy Policy     

Windy City Media Group publishes Windy City Times,
The Bi-Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.